Drugs / PhosphoLean
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00153790 | Apr 2005 → May 2006 | — | The Cooper Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PhosphoLean | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00153790 ↗ |
| Modality | Other / unclassified | “taking the dietary supplement containing a soy lecithin-derived N-oleoyl-phosphatidyl-ethanolamine (NOPE) and caffeine free Green Tea-derived epigallocathchin gallate (EGCG)” NCT00153790 ↗ |